Drug resistance
The Drug Resistance category focuses on detecting critical genetic markers associated with antimicrobial resistance, supporting effective treatment decisions and infection control. Rapid identification of resistance determinants helps combat multidrug-resistant (MDR) pathogens and limits the spread of resistant strains. This category includes detection of:
Genetic Markers of Antibiotic Resistance: Key resistance genes such as MDR KPC/OXA-48, Metallo-β-lactamases (MBL) responsible for the resistance to β-lactam antibiotics (beta-lactam), MCR-1 (colistin resistance), and Vancomycin-resistant Enterococci (VRE) markers.
Methicillin-resistant Staphylococcus aureus (MRSA): Detection of the mecA gene responsible for methicillin resistance, crucial for managing staphylococcal infections.
Real-time PCR kits provide sensitive and specific detection of these resistance genes from clinical samples in routine and specialized laboratory workflows. Available in CE IVD-marked and research use only (RUO) versions, these PCR assays enable rapid, accurate, and reliable resistance profiling from clinical samples to guide antimicrobial stewardship and improve patient outcomes.